Bio-Rad Laboratories, Inc. (BIO-B)
-NYSE 115.41 0.00(0.00%) May 21
| Prev Close: | 115.41 |
|---|
| Open: | N/A |
|---|
| Bid: | 114.95 x 100 |
|---|
| Ask: | 115.89 x 100 |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | 1.19 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 93.98 - 125.50 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 783 |
|---|
| Market Cap: | 3.29B |
|---|
| P/E (ttm): | 21.75 |
|---|
| EPS (ttm): | 5.31 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Bio-Rad Named One of the 'Best Places to Work 2013' in the San Francisco Bay AreaMarketwired(Mon, May 13)
- Bio-Rad Reports First-Quarter 2013 Financial ResultsMarketwired(Tue, May 7)
- Bio-Rad to Report First-Quarter 2013 Financial Results Tuesday, May 7, 2013Marketwired(Fri, Apr 12)
- Bio-Rad Files Form 10-K for the Year Ended December 31, 2012Marketwired(Mon, Mar 18)
- Bio-Rad Receives the 2012 Frost & Sullivan North America Laboratory Researchers' Choice Award for Future Market LeaderPR Newswire(Tue, Mar 12)
- Bio-Rad Form 10-K Filing DelayedMarketwired(Mon, Mar 4)
- Bio-Rad Reports Fourth-Quarter and Full-Year 2012 Financial ResultsMarketwired(Tue, Feb 26)
- Bio-Rad to Report Fourth-Quarter and Full-Year 2012 Financial Results Tuesday, February 26, 2013Marketwired(Mon, Jan 28)
- Bio-Rad Completes AbD Serotec Purchaseat Motley Fool(Thu, Jan 10)
- Bio-Rad Acquires AbD Serotec, a Division of MorphoSys AGMarketwired(Thu, Jan 10)
- Bio-Rad and Lamprogen Partner to Commercialize Fluorescent Particles Used for ResearchMarketwired(Thu, Dec 20)
- Bio-Rad to Buy Germany's AbD Serotec for $70 Millionat Motley Fool(Mon, Dec 17)
- Bio-Rad Labs to buy AbD Serotec for $69.8 millionAP(Mon, Dec 17)
- Bio-Rad Signs Definitive Agreement to Acquire AbD SerotecMarketwired(Sun, Dec 16)
- Bio-Rad Reports Third-Quarter 2012 Financial ResultsMarketwired(Tue, Nov 6)
Reports
- No Reports available for BIO-B at this time.
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 1.58 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
()
: | N/A |
|---|
| Quarterly EPS Est
()
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Bio-Rad Laboratories, Inc. manufactures and supplies products and systems used to separate complex chemical and biological materials, and to identify, analyze, and purify their components for life science research, healthcare, analytical chemistry...
View More 
0.42%